John F Ginascol Insider Trading $ABT ABBOTT LABORATORIES
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John F Ginascol.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John F Ginascol. John F Ginascol is Executive Vice President in ABBOTT LABORATORIES ($ABT).
John F Ginascol in ABBOTT LABORATORIES
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John F Ginascol: Executive Vice President
Holdings: 104,409 shares
Current Value: $4,478,102
Latest Transaction: Feb 23 2021
$ABT Market Capitalization: $62.37B
$ABT Previous Close: $42.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John F Ginascol in ABBOTT LABORATORIES
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | EXECUTIVE VICE PRES ... | Option Exercise | A | 124.04 | 78,966 | 9,794,943 | 78,966 | |
| Feb 23 2021 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | EXECUTIVE VICE PRES ... | Grant | A | 0.00 | 15,406 | 0 | 104,409 | 89 K to 104.4 K (+17.31 %) |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 44.40 | 39,953 | 1,773,913 | 0 | |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 38.40 | 20,133 | 773,107 | 0 | |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 47.00 | 12,012 | 564,564 | 45,709 | |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Payment of Exercise | F | 109.47 | 47,772 | 5,229,601 | 89,003 | 136.8 K to 89 K (-34.93 %) |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 44.40 | 39,953 | 1,773,913 | 136,775 | 96.8 K to 136.8 K (+41.26 %) |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 38.40 | 20,133 | 773,107 | 96,822 | 76.7 K to 96.8 K (+26.25 %) |
| Sep 03 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 47.00 | 12,012 | 564,564 | 76,689 | 64.7 K to 76.7 K (+18.57 %) |
| Jun 05 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Payment of Exercise | F | 92.62 | 1,768 | 163,752 | 64,677 | 66.4 K to 64.7 K (-2.66 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 38.40 | 63,200 | 2,426,880 | 20,133 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 96.26 | 39,234 | 3,776,630 | 66,445 | 105.7 K to 66.4 K (-37.13 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 95.57 | 23,966 | 2,290,421 | 105,679 | 129.6 K to 105.7 K (-18.49 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 38.40 | 63,200 | 2,426,880 | 129,645 | 66.4 K to 129.6 K (+95.12 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 38.40 | 63,200 | 2,426,880 | 20,133 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 96.26 | 39,234 | 3,776,630 | 66,445 | 105.7 K to 66.4 K (-37.13 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 95.57 | 23,966 | 2,290,421 | 105,679 | 129.6 K to 105.7 K (-18.49 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 38.40 | 63,200 | 2,426,880 | 129,645 | 66.4 K to 129.6 K (+95.12 %) |
| Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | A | 87.72 | 114,940 | 10,082,537 | 114,940 | |
| Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Grant | A | 0.00 | 18,855 | 0 | 75,297 | 56.4 K to 75.3 K (+33.41 %) |
| Jun 05 2019 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | A | 76.12 | 62,725 | 4,774,627 | 62,725 | |
| Jun 05 2019 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Grant | A | 0.00 | 11,967 | 0 | 60,584 | 48.6 K to 60.6 K (+24.61 %) |
Page: 1